EKF Diagnostics Holdings plc (LON:EKF – Get Free Report) shares passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 27.26 and traded as low as GBX 25.50. EKF Diagnostics shares last traded at GBX 25.50, with a volume of 71,332 shares.
EKF Diagnostics Stock Performance
The business’s fifty day moving average price is GBX 25.30 and its 200-day moving average price is GBX 27.25. The stock has a market capitalization of £111.02 million, a PE ratio of 18.89 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77.
Insider Activity
In other EKF Diagnostics news, insider Julian Baines acquired 85,000 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were bought at an average price of GBX 23 per share, for a total transaction of £19,550. Company insiders own 39.62% of the company’s stock.
EKF Diagnostics Company Profile
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
- Five stocks we like better than EKF Diagnostics
- With a $7 Valuation, NNVC Could Disrupt the Biotech Space in 2026
- BNZI Posts Record Q3 Revenue – See What’s Driving It.
- Do you know what Amazon is planning for January 1?
- Turn your “dead money” into $306+ monthly (starting this month)
- [How To] Claim Your Pre-IPO Stake In SpaceX!
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
